Johnson & Johnson Non-GAAP EPS of $2.59 beats by $0.06, revenue of $25.4B in-line (JNJ:NYSE)
· seekingalpha.com
Johnson & Johnson Q3 earnings: Non-GAAP EPS beat, revenue +5.8% Y/Y, and 2026 guidance raised to $101.2B sales and $11.10 EPS.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...